The global Cardiac Surgery Devices Market is set to grow steadily over the next decade, with its valuation expected to reach USD 1.8 billion in 2024. By 2034, the market is projected to expand to USD 2.5 billion, representing a CAGR of 3.7% during the forecast period.
The increasing prevalence of cardiovascular diseases worldwide is a key driver of this growth. The rising adoption of advanced surgical technologies, including minimally invasive procedures, is enhancing patient outcomes and boosting demand for cardiac surgery devices. Furthermore, the growing geriatric population and advancements in medical infrastructure are contributing to the steady expansion of the market.
Manufacturers are focusing on innovations such as robotic-assisted surgical systems and improved durability in devices like heart valves and pacemakers. Emerging markets are also playing a significant role, with governments and private sectors investing in healthcare infrastructure to meet rising demands.
A Full Report Analysis – https://www.futuremarketinsights.com/reports/cardiac-surgery-devices-market
Key Takeaways:
- Market Size: Valued at USD 1.8 billion in 2024, projected to reach USD 2.5 billion by 2034.
- Growth Rate: Anticipated CAGR of 3.7% from 2024 to 2034.
- Market Drivers: Rising cardiovascular disease prevalence, advancements in minimally invasive technologies, and increasing healthcare investments.
- Emerging Trends: Adoption of robotic-assisted surgeries and improved device durability, with strong growth in emerging markets.
Growth Drivers
- Increasing Incidence of Cardiovascular Diseases: The rising prevalence of cardiovascular conditions, including heart disease and related disorders, is driving the demand for cardiac surgery devices.
- Advancements in Surgical Techniques: Innovations in minimally invasive surgical techniques and technologies are enhancing the effectiveness of cardiac procedures, leading to increased adoption of advanced surgical devices.
- Aging Population: The growing elderly population, which is more susceptible to cardiovascular diseases, contributes significantly to the demand for cardiac surgery interventions.
- Healthcare Infrastructure Improvements: Enhanced healthcare facilities and access to advanced medical technologies are facilitating the growth of the cardiac surgery devices market.
Regional Insights
- The United States is expected to dominate the market due to high healthcare expenditures and a significant patient population requiring cardiac interventions.
- Emerging markets in the Asia-Pacific region are anticipated to show strong growth rates driven by increasing healthcare access and rising awareness about cardiovascular health.
Prominent Companies in the Market
- Abbott Laboratories
- Medtronic Plc.
- Boston Scientific Corporation
- Johnson & Johnson (Ethicon)
- B. Braun Melsungen AG
- Terumo Corporation
- LivaNova PLC
- Edwards Lifesciences Corporation
- Cardinal Health
- Stryker Corporation
- Cook Medical
- Philips Healthcare
- Getinge Group
- Hologic, Inc.
- AtriCure, Inc.
- Lepu Medical Technology Co. Ltd.
- C.R. Bard (now part of BD)
- Zoll Medical Corporation
- Merit Medical Systems, Inc.
- Asahi Intecc Co., Ltd.
Cardiac Surgery Devices Market Segmentation
By Product:
Referring to the cardiac surgery devices industry analysis, the market is segmented into heart lung machine, breathing heart surgery systems, catheters, perfusion disposables, etc.
By Procedure:
On the basis of procedures, the market is segmented into coronary artery bypass grafting and minimally invasive surgeries.
By End-users:
Sector analysis suggests that the market is segmented into hospitals and ambulatory surgical centers on the basis of end-users.
By Region:
The market can be segmented by region, encompassing North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube